Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary
Clinical trial NCT03206177 · COMPLETED
Trial details
- NCT number
- NCT03206177
- Sponsor
- University of Oklahoma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-23
- Primary completion
- 2021-07-28
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.